Update on the classification and labelling of Titanium Dioxide in powder form
Ingredients: TITANIUM DIOXIDE

Date of publication: 23/11/2022

The EU General Court annuls the Commission Delegated Regulation of 2019 in so far as it concerns the harmonised classification and labelling of Titanium Dioxide as a carcinogenic substance by inhalation in certain powder forms.

BACKGROUND

Titanium dioxide is an inorganic chemical substance used, in particular in the form of a white pigment, for its colourant and covering properties in various products, ranging from paints to medicinal products and cosmetic products. In 2016, the competent French authority submitted to the European Chemicals Agency (ECHA) a proposal to classify Titanium Dioxide as a carcinogenic substance.

The following year, ECHA’s Committee for Risk Assessment (‘the RAC’) adopted an opinion classifying Titanium Dioxide as a category 2 carcinogen, including the hazard statement ‘H 351 (inhalation)’.

On the basis of the RAC Opinion, the European Commission adopted Regulation 2020/217, by which it proceeded with the harmonised classification and labelling of titanium dioxide, recognising that that substance was suspected of being carcinogenic to humans, by inhalation, in powder form containing 1% or more of particles of a diameter equal to or below 10 μm.

An action for annulment seeks the annulment of acts of the institutions of the European Union that are contrary to EU law. The EU Court of Justice considered that the European Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.

WHAT’S NEW?

The EU General Court annuls the Commission Delegated Regulation of 2019 in so far as it concerns the harmonised classification and labelling of Titanium Dioxide as a carcinogenic substance by inhalation in certain powder forms.

References:

1. Court of Justice of the European Union. Press Release No. 190/22 – Judgment of the General Court in Joined Cases T-279/20, T-288/20 and T-283/20.

other
REGULATORY UPDATES

SCCS Preliminary Opinion on Sodium Bromothymol Blue (C186) as hair dyeing

Ingredients: SODIUM BROMOTHYMOL BLUE (C186)

Date of publication: 28/10/2022

Following the request from the EU Commission for a scientific opinion on the hair dye Sodium Bromothymol Blue (C186), on October 2022 the Scientific Committee on Consumer Safety (SCCS) issued a preliminary opinion. In light of the data provided, when used in non-oxidative hair colouring products up to a maximum on-head concentration of 0.5%, the SCCS is of the opinion that the complete safety of Sodium Bromothymol Blue could not be assessed.

Read More »

Regulation (EU) 2022/1531 – OMNIBUS ACT V – applicable as of 17 December 2022

Ingredients: METHYL SALICYLATE, SODIUM HYDROXYMETHYLGLYCINATE, DBMC, MIBK

Date of publication: 15/09/2022

Date of application: 17/12/2022

The European Commission has published the Commission Regulation (EU) 2022/1531, which amends the Regulation (EC) No 1223/2009 as regards the use in cosmetic products of certain substances classified as CMR, by adding new entries to Annex II and Annex III and revising an entry in Annex V.

Read More »
Any REGULATORY QUESTION?